U.S. General Merchandise and Department Stores Stock News

NYSE:OKE
NYSE:OKEOil and Gas

Assessing ONEOK (OKE) Valuation After Recent Share Price Weakness

What ONEOK’s Recent Trading Tells You About the Stock ONEOK (OKE) has seen its stock slide about 6% over the past month, even as its total return over the past 3 years sits well above a multiple of 7x, putting recent moves in context. See our latest analysis for ONEOK. The recent 1-day share price return of down 3.54% and 7-day share price return of down 10.73% contrast with a year-to-date share price return of 12.91% and a 3-year total shareholder return of 66.76%. This suggests that...
NYSE:ADM
NYSE:ADMFood

Assessing Archer-Daniels-Midland (NYSE:ADM) Valuation After Strong Recent Share Price Momentum

Recent performance snapshot With no single headline event driving recent trading, Archer-Daniels-Midland (ADM) has drawn interest as the stock’s recent moves contrast with its longer track record of total returns and its current valuation metrics. See our latest analysis for Archer-Daniels-Midland. ADM’s recent share price move to around US$79.78 comes after a strong run, with a 30 day share price return of 7.42% and a 1 year total shareholder return of 70.48%. This suggests that momentum has...
NasdaqGM:GDS
NasdaqGM:GDSIT

GDS Holdings Refreshes Audit Oversight As Investors Weigh Governance Risks

GDS Holdings (NasdaqGM:GDS) announced that long-serving Chairman Mr. Lim Ah Doo has resigned from the board. Ms. Hua (Kathy) Chen has been appointed as an independent director and Chair of the Audit Committee, taking over key governance responsibilities. The leadership transition marks a change in board and committee oversight after Mr. Lim’s 11-year contribution to the company’s corporate governance. For investors watching NasdaqGM:GDS, this governance update comes with the stock at a...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Ocular Therapeutix (OCUL) Valuation Check After Recent Trading And AXPAXLI Growth Expectations

Ocular Therapeutix (OCUL) has been drawing fresh attention after recent trading moves, with the stock closing at US$9.01 and posting mixed short term returns across the past week, month and past 3 months. See our latest analysis for Ocular Therapeutix. Recent trading puts that US$9.01 share price in context, with short term share price momentum firming over the past week but still weaker year to date, while longer term total shareholder returns over one and three years remain positive. If you...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel’s US$3.3b India Plant Raises Questions On Growth And Valuation

Intel (NasdaqGS:INTC) and 3DGS plan to build a substrate manufacturing plant in Odisha, India, with a joint investment of US$3.3b. The project is intended to support growth in India's semiconductor ecosystem and expand regional supply chain capacity. Government incentives in India are a key factor in the decision to locate the facility in Odisha. The plant is expected to create high skilled jobs and contribute to India's chip manufacturing ambitions. For Intel, a major global semiconductor...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

A Look At NextDecade (NEXT) Valuation After Citi Initiates Coverage With A Buy Rating

Citi’s initiation of coverage on NextDecade (NEXT) has put fresh attention on the stock, as investors weigh the firm’s view against approaching milestones at the company’s Rio Grande LNG project in Texas. See our latest analysis for NextDecade. At a share price of US$7.91, NextDecade has seen short term momentum cool with a 7 day share price return that declined 6.5%, but the 90 day share price return of 46.75% and 5 year total shareholder return of 224.18% point to a stock where sentiment...
NYSE:GE
NYSE:GEAerospace & Defense

A Look At General Electric’s Valuation As New Air Force Engine Contract And Strong Q1 2026 Results Lift Optimism

General Electric (GE) is back in focus after GE Aerospace secured a U.S. Air Force contract to advance its GE426 engine for the Autonomous Collaborative Platform program, while also reporting robust Q1 2026 results and reaffirmed guidance. See our latest analysis for General Electric. The latest U.S. Air Force engine contract and solid Q1 2026 update appear to be feeding into renewed optimism, with General Electric's 7 day share price return of 6.9% and 30 day share price return of 14.2%...
NYSE:EL
NYSE:ELPersonal Products

Is Estée Lauder (EL) Share Rebound Signalling A Possible Valuation Opportunity Now

Wondering whether Estée Lauder Companies at around US$88.95 is offering fair value or an opportunity? This article walks through what the current price might be telling you. The stock is up 0.7% over the past week and 17.5% over the past month. However, it remains down 16.7% year to date, with a 34.8% gain over 1 year but declines of 50.0% over 3 years and 68.4% over 5 years. The recent rebound therefore sits against a much weaker longer-term picture. Recent headlines around Estée Lauder...
NYSE:LEU
NYSE:LEUOil and Gas

A Look At Centrus Energy (LEU) Valuation After New Federal Funding And HALEU Expansion Plans

Centrus Energy (LEU) has drawn fresh investor attention after securing significant federal funding and outlining a substantial expansion of its centrifuge manufacturing plant, reinforcing its role as the only licensed HALEU producer in the Western world. See our latest analysis for Centrus Energy. The federal funding and HALEU expansion news come after a period where the share price has fallen 33% year to date to US$182.47, even as the 1 year total shareholder return is 43.77% and the 5 year...
NYSE:TOST
NYSE:TOSTDiversified Financial

Is Toast (TOST) Offering Value After Recent Share Price Rebound?

Wondering if Toast's current share price offers value or just extra risk? This article walks through what the numbers say so you can judge whether the stock fits your approach. Toast shares closed at US$26.03, with the stock up 12.4% over the last 7 days, but down 9.0% over 30 days, 23.5% year to date, and 38.3% over the past year, while still showing a 23.5% gain over 3 years. Recent headlines have focused on Toast as a listed point of sale and payments platform for restaurants,...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

Is It Too Late To Revisit F5 (FFIV) After Its Strong Year To Date Rally?

If you are wondering whether F5 at around US$383 per share offers fair value or is pricing in too much optimism, you are not alone. The stock is down 2.6% over the last week, but up 16.9% over the past month, 49.4% year to date, 34.4% over the last year, 161.3% over three years and 103.1% over five years, which naturally raises questions about what is now baked into the price. Recent coverage has focused on F5's role in application security and multi cloud networking, as investors weigh how...
NYSE:FSS
NYSE:FSSMachinery

Assessing Federal Signal (FSS) Valuation After Recent Share Price Pullback

Federal Signal (FSS) is back on investor radars after recent share price softness, with the stock down about 12% over the past month and roughly 8% over the past 3 months. See our latest analysis for Federal Signal. At a share price of $106.70, the stock has given up some ground recently, with the 7 day share price return down 5.25% and the 30 day share price return down 12.17%. However, the 1 year total shareholder return of 14% and 5 year total shareholder return of 155.39% still point to a...
NYSE:UBER
NYSE:UBERTransportation

Uber Expands World Cup, Hotel And EV Push As Shares Look Undervalued

Uber Technologies (NYSE:UBER) has launched Uber Shuttle services for the FIFA World Cup, targeting large scale event transportation. The company has integrated with hotel platform Mews, enabling ride bookings at more than 15,000 hotels worldwide. Uber has entered an electric vehicle partnership with JSW Group in India to develop EVs tailored to local ride hailing needs. Uber Technologies, trading at about $70.4, is rolling out these initiatives while the stock is down 15.0% year to date and...
NasdaqCM:DUOT
NasdaqCM:DUOTSoftware

A Look At Duos Technologies Group (DUOT) Valuation As 2026 Revenue Outlook Is Reaffirmed And Visibility Rises

Duos Technologies Group (DUOT) has reaffirmed its expectation for 2026 revenue to exceed US$50 million and is preparing to present at the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026. See our latest analysis for Duos Technologies Group. The reaffirmed 2026 revenue outlook and upcoming Craig Hallum conference appearance come after a sharp 30 day share price return of 63.64% and a 1 year total shareholder return of 76.47%. This suggests momentum has been building...
NYSEAM:UMAC
NYSEAM:UMACElectronic

A Look At Unusual Machines (UMAC) Valuation After Recent Sharp Share Price Momentum

Unusual Machines (UMAC) has been drawing attention recently, with investors weighing its position in the commercial drone industry, its current share price of US$31.78, and a market cap of about US$1.41b. See our latest analysis for Unusual Machines. Recent trading has been intense, with a 7.36% 1-day share price return, a 131.30% 30-day share price return and a very large 1-year total shareholder return, suggesting strong momentum and rapidly shifting expectations around growth and risk. If...
NYSE:GAP
NYSE:GAPSpecialty Retail

Gap (GPS) Margin Improvement Reinforces Bullish Narrative Despite Modest Revenue Growth

Gap (GPS) opened Q1 2027 with revenue of US$3,497 million and basic EPS of US$0.92, set against trailing twelve month revenue of US$15.4 billion and EPS of US$2.59 that were tied to 2.3% yearly revenue growth and 9.5% earnings growth. Over the past year, revenue moved from US$15.1 billion in Q1 2026 to US$15.4 billion in Q1 2027 while EPS shifted from US$2.34 to US$2.59, giving investors a clear view of steady top line and earnings expansion. With net profit margins improving from 5.8% to...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Assessing Teladoc Health (TDOC) Valuation After Walmart Partnership And Mixed Earnings Reaction

Teladoc Health (TDOC) is back in focus after two key developments: a new partnership that puts its virtual care services on Walmart’s Better Care Services platform and an earnings update that drew a sharp stock reaction. See our latest analysis for Teladoc Health. The recent Walmart partnership and earnings update come on top of a sharp 44.68% 90 day share price return and 27.90% 30 day share price return. However, the 3 year total shareholder return is still down 68.91%, so recent momentum...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Gilead Sciences (GILD) Valuation Check After Hepcludex Wins First FDA Approval For Hepatitis Delta

The U.S. Food and Drug Administration has granted accelerated approval for Hepcludex, the first approved treatment for chronic hepatitis delta virus infection in U.S. adults, which is putting Gilead Sciences (GILD) in focus for many healthcare investors. See our latest analysis for Gilead Sciences. Alongside the Hepcludex approval and updates around Livdelzi and Trodelvy, Gilead’s share price has risen 10.55% year to date and its 1 year total shareholder return is 25.37%, which points to firm...
NYSE:V
NYSE:VDiversified Financial

Visa Taps AI Agents And Stablecoins To Shape Future Payment Flows

Visa (NYSE:V) has invested in and partnered with AI platform Replit, extending its reach into agentic software that can initiate and execute payments. The company is also playing a growing role in powering crypto and stablecoin payments through its card network. These moves reflect Visa's intention to stay relevant in developer led commerce and new payment rails alongside traditional card transactions. Regulatory developments such as the GENIUS Act are helping formalize the use of crypto and...
NYSE:BDX
NYSE:BDXMedical Equipment

Is BD’s Expanded Urology Laser Platform a Meaningful Edge in Procedural Efficiency for BDX?

Earlier this month, Becton, Dickinson and Company introduced the Elyra and Elyra Plus Thulium Fiber Laser Systems in the US, expanding its kidney stone and soft tissue urologic care portfolio with an air-cooled, small-footprint platform aimed at improving procedural efficiency and workflow. The launch underscores BD’s push toward an end-to-end urologic stone management offering, integrating access, visualization, fragmentation, removal, and drainage into a single, cohesive ecosystem for...
NYSE:RACE
NYSE:RACEAuto

Ferrari (RACE) Valuation Check After Recent Share Pullback And Premium P/E Multiple

Without a specific news catalyst, Ferrari (NYSE:RACE) is currently in focus for investors mainly because of its recent share performance, with the stock roughly flat over the past month but lower over the past three months. See our latest analysis for Ferrari. Ferrari's recent 7 day share price return, down 2.3%, and 90 day share price return, down 10.5%, contrast with a 5 year total shareholder return of 63.2%. This suggests that long term holders have still seen meaningful gains. If you are...
NYSE:EPAM
NYSE:EPAMIT

How Investors May Respond To EPAM (EPAM) Granting Shareholders New Rights To Call Special Meetings

EPAM Systems’ May 21, 2026 annual meeting approved an amendment to its certificate of incorporation enabling shareholders to call special meetings, even as investors rejected a separate advisory proposal seeking similar rights. This mixed governance outcome, alongside sector-wide analyst caution on digital IT services and AI-related disruption, highlights growing shareholder focus on both control rights and EPAM’s evolving role in an uncertain technology services landscape. We’ll now examine...
NYSE:DUK
NYSE:DUKElectric Utilities

Duke Energy Links Customer Storage To Grid Goals And Investor Questions

Duke Energy (NYSE:DUK) has launched its PowerShare Storage demand response program for nonresidential customers, using customer battery systems to support the grid in return for bill credits. Nonresidential customers participating in the program can receive bill credits when they allow Duke Energy to draw on their energy storage during peak grid demand events. Separate regulatory changes in Florida mean customers there are set to see lower electricity bills during the summer months. The Duke...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

Did Mixed Wall Street Caution and Contrarian Interest Just Shift MercadoLibre's (MELI) Investment Narrative?

In mid-May 2026, MercadoLibre drew mixed reactions as major banks flagged margin and monetization pressures while prominent market commentators highlighted it as a contrarian opportunity amid weak retail sentiment and evidence of institutional accumulation. This contrast between cautious analyst views and growing interest from professional investors and media voices has sharpened the debate over MercadoLibre’s long-term role in Latin American e-commerce and fintech. Now we’ll examine how...